Administration of teriparatide for four years cyclically compared to two years daily in treatment na ïve and alendronate treated women

We evaluated if equivalent doses of TPTD given cyclically over 4-years could increase BMD>2-years of daily TPTD in 2 cohorts of women; previously untreated (Rx-Na ïve) and women previously treated with ALN (ALN-Rx).

Source: Bone - October 21, 2018 Category: Orthopaedics Authors: Felicia Cosman, Jeri W. Nieves, Catherine Roimisher, Simon Neubort, Donald J. McMahon, David W. Dempster, Robert Lindsay Tags: Full Length Article Source Type: research